GRL093-22 is a potent and selective G protein-coupled receptor kinase (GRK) inhibitor, with IC 50 s of 60 and 40 nM for GRK5 and GRK6 , respectively. GRL093-22 has the potential for the research of heart failure and multiple myeloma.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > G Protein-coupled Receptor Kinase (GRK)
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。